RESTASIS MULTIDOSE
ABBVIE CORPORATION
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of RESTASIS MULTIDOSE in Canada?
A shortage of RESTASIS MULTIDOSE 0.05% is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 8, 2026), but it has not started yet.
Why is RESTASIS MULTIDOSE not available?
The reason the manufacturer reported: Demand increase for the drug.
When will RESTASIS MULTIDOSE be available again?
The manufacturer's estimated resolution date is October 14, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
RESTASIS
ABBVIE CORPORATION
Other Products
SANDIMMUNE ORAL SOL 100MG/ML
SANDOZ CANADA INC
SANDIMMUNE SOFT GELATIN CAP 100MG
SANDOZ CANADA INC
SANDIMMUNE I.V.
NOVARTIS PHARMACEUTICALS CANADA INC
NEORAL
NOVARTIS PHARMACEUTICALS CANADA INC
SANDIMMUNE SOFT GELATINE CAP 25MG
SANDOZ CANADA INC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-10-14
~16 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02476835
Strength
0.05%
Dosage Form
EMULSION
Route
OPHTHALMIC
Active Ingredient
CYCLOSPORINE
Tier
Unrated
Last Updated
2026-09-08
Reason for Shortage
Demand increase for the drug.
Other Products from ABBVIE CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
35MG · DIN 02246896
150MG · DIN 02316838
35MG · DIN 02370417
0.5% · DIN 01968300
0.4% · DIN 02248722
0.45% · DIN 02369362
0.2% · DIN 02236876
0.15% · DIN 02248151
10MG · DIN 02443910
50UNIT · DIN 02531577
100UNIT · DIN 01981501
200UNIT · DIN 02531585